Supplementary Materials for Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: A retrospective cohort study

Supplementary materials for the manuscript "Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: A retrospective cohort study" include tables and figures outlining combination treatment medication dosing (e.g., initial, max, ADE-associated doses of spironolactone and oral minoxidil), patient-reported reasons for therapeutic discontinuation, frequency of adverse effects attributed to medications within the combination regimen, ADE risk factor regression analysis, and cohort selection.